These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32058014)

  • 1. Programming implantable cardioverter-defibrillator in primary prevention: Guideline concordance and outcomes.
    Ananwattanasuk T; Tanawuttiwat T; Chokesuwattanaskul R; Lathkar-Pradhan S; Barham W; Oral H; Thakur RK; Jongnarangsin K
    Heart Rhythm; 2020 Jul; 17(7):1101-1106. PubMed ID: 32058014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of supraventricular arrhythmias on the outcomes of guideline-compliant implantable cardioverter defibrillator programming.
    Teerawongsakul P; Ananwattanasuk T; Chokesuwattanaskul R; Shah M; Lathkar-Pradhan S; Barham W; Oral H; Thakur RK; Jongnarangsin K; Tanawuttiwat T
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):794-801. PubMed ID: 38384108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programming of implantable cardioverter defibrillators for primary prevention: outcomes at centers with high vs. low concordance with guidelines.
    Teerawongsakul P; Ananwattanasuk T; Chokesuwattanaskul R; Shah M; Lathkar-Pradhan S; Barham W; Oral H; Thakur RK; Jongnarangsin K; Tanawuttiwat T
    J Interv Card Electrophysiol; 2023 Sep; 66(6):1359-1366. PubMed ID: 36422768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    J Interv Card Electrophysiol; 2020 Oct; 59(1):135-144. PubMed ID: 31960345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).
    Ruwald AC; Schuger C; Moss AJ; Kutyifa V; Olshansky B; Greenberg H; Cannom DS; Estes NA; Ruwald MH; Huang DT; Klein H; McNitt S; Beck CA; Goldstein R; Brown MW; Kautzner J; Shoda M; Wilber D; Zareba W; Daubert JP
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):785-92. PubMed ID: 25136077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    Heart Rhythm; 2020 Jan; 17(1):e220-e228. PubMed ID: 31103461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL;
    Europace; 2019 Sep; 21(9):1442-1443. PubMed ID: 31090914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy).
    Biton Y; Huang DT; Goldenberg I; Rosero S; Moss AJ; Kutyifa V; McNitt S; Strasberg B; Zareba W; Barsheshet A
    Heart Rhythm; 2016 Apr; 13(4):888-93. PubMed ID: 26711799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defensive Implantable Cardioverter-Defibrillator Programming Is Safe and Reduces Inappropriate Therapy　- Comparison of 3 Programming Strategies in 1,471 Patients.
    Burger AL; Stojkovic S; Schmidinger H; Ristl R; Pezawas T
    Circ J; 2018 Nov; 82(12):2976-2982. PubMed ID: 30270313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study.
    Kutyifa V; Daubert JP; Schuger C; Goldenberg I; Klein H; Aktas MK; McNitt S; Stockburger M; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e001965. PubMed ID: 26743237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Well Do Results From Randomized Clinical Trials and/or Recommendations for Implantable Cardioverter-Defibrillator Programming Diffuse Into Clinical Practice?
    Varma N; Jones P; Wold N; Cronin E; Stein K
    J Am Heart Assoc; 2019 Feb; 8(3):e007392. PubMed ID: 30712432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of appropriate implantable cardioverter-defibrillator therapy and implications for guideline-based driving restrictions.
    Kim MH; Zhang Y; Sakaguchi S; Goldberger JJ;
    Heart Rhythm; 2015 Aug; 12(8):1728-36. PubMed ID: 25933503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.
    Ruwald MH; Zareba W; Jons C; Zhang C; Ruwald AC; Olshansky B; McNitt S; Bloch Thomsen PE; Shoda M; Merkely B; Moss AJ; Kutyifa V
    Circulation; 2013 Aug; 128(7):694-701. PubMed ID: 23881862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    J Arrhythm; 2019 Jun; 35(3):485-493. PubMed ID: 31293697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic ICD programming and outcomes.
    Khan P; Jahagirdar N; Laybourn M; Harding I; Cannatà A; Bromage DI; Shabeeh H; Kabunga P; Petzer E; Murgatroyd F; Scott PA
    Pacing Clin Electrophysiol; 2021 Dec; 44(12):1995-2004. PubMed ID: 34672370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study.
    Clementy N; Challal F; Marijon E; Boveda S; Defaye P; Leclercq C; Deharo JC; Sadoul N; Klug D; Piot O; Gras D; Bordachar P; Algalarrondo V; Fauchier L; Babuty D;
    Heart Rhythm; 2017 Feb; 14(2):211-217. PubMed ID: 27989789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
    Guerra F; Palmisano P; Dell'Era G; Ziacchi M; Ammendola E; Bonelli P; Patani F; Cupido C; Devecchi C; Accogli M; Occhetta E; Santangelo L; Biffi M; Boriani G; Capucci A;
    Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.
    Buber J; Luria D; Gurevitz O; Bar-Lev D; Eldar M; Glikson M
    Europace; 2014 Feb; 16(2):227-34. PubMed ID: 24108231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feedback to providers improves evidence-based implantable cardioverter-defibrillator programming and reduces shocks.
    Silver MT; Sterns LD; Piccini JP; Joung B; Ching CK; Pickett RA; Rabinovich R; Liu S; Peterson BJ; Lexcen DR;
    Heart Rhythm; 2015 Mar; 12(3):545-553. PubMed ID: 25460168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT.
    Schuger C; Daubert JP; Zareba W; Rosero S; Yong P; McNitt S; Kutyifa V
    Heart Rhythm; 2021 Mar; 18(3):399-403. PubMed ID: 33232811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.